New Ray Medicine International Holding Ltd., a company incorporated in Bermuda, has announced a proposed capital reorganisation. This restructuring will involve a share consolidation, capital reduction, and share sub-division, consolidating every ten issued and unissued existing shares of par value HK$0.05 into one consolidated share of par value HK$0.50. Subsequently, each authorised but unissued consolidated share will be subdivided into fifty new shares of par value HK$0.01 each. The move aims to address market price extremities in accordance with Hong Kong Stock Exchange rules.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。